Cargando…
Health technology assessment of biosimilars worldwide: a scoping review
BACKGROUND: Health technology assessment (HTA) should provide an assessment of a technology’s effects on health and of the related social, economic, organisational and ethical issues. HTA reports on biosimilars can specifically assess their immunogenicity, their extrapolation to one or more conditio...
Autores principales: | Ascef, Bruna de Oliveira, Lopes, Ana Carolina de Freitas, de Soárez, Patrícia Coelho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448328/ https://www.ncbi.nlm.nih.gov/pubmed/32843051 http://dx.doi.org/10.1186/s12961-020-00611-y |
Ejemplares similares
-
Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
por: Ascef, Bruna de Oliveira, et al.
Publicado: (2023) -
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis
por: de Oliveira Ascef, Bruna, et al.
Publicado: (2023) -
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
por: Ascef, Bruna O., et al.
Publicado: (2021) -
Patient and public involvement in health technology decision-making processes in Brazil
por: Lopes, Ana Carolina de Freitas, et al.
Publicado: (2020) -
Health Technology Assessment: informed by science or in the service of politics?
por: de Soárez, Patrícia Coelho
Publicado: (2021)